Overexpression of HIF Prolyl-Hydoxylase-2 transgene in the renal medulla induced a salt sensitive hypertension

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 11, 2012, Pages 2701-2707

  Zhu, Qing ^a   Liu, Miao ^a   Han, Wei Qing ^a   Li, Pin Lan ^a   Wang, Zhengchao ^a   Li, Ningjun ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gene transfection; Hypoxia inducible factor 1 ; Pressure natriuresis; Sodium excretion; Transcription factor

Indexed keywords

HIF1A PROTEIN, RAT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHD2 PROTEIN, RAT; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SODIUM;

ADAPTATION; ANIMAL; ARTICLE; BLOOD PRESSURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HYPERTENSION; KIDNEY MEDULLA; MALE; METABOLISM; NATRIURESIS; PATHOPHYSIOLOGY; PRESSURE; RAT; SALT INTAKE; SPRAGUE DAWLEY RAT; TRANSGENE; TRANSGENIC RAT; URINE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BLOOD PRESSURE; GENE EXPRESSION REGULATION; HYPERTENSION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY MEDULLA; MALE; NATRIURESIS; PRESSURE; PROCOLLAGEN-PROLINE DIOXYGENASE; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC; SODIUM; SODIUM CHLORIDE, DIETARY; TRANSGENES;

RATTUS;

EID: 84868115582     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2012.01590.x     Document Type: Article

References (57)

1. Weinberger MH, Miller JZ, Luft FC, et al. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986; 8: II127-34.
2. Chrysant GS, Bakir S, Oparil S. Dietary salt reduction in hypertension - what is the evidence and why is it still controversial? Prog Cardiovasc Dis. 1999; 42: 23-38.
3. Campese V. Salt sensitivity in hypertension. Renal and cardiovascular implications [clinical conference]. Hypertension. 1994; 23: 531-50.
4. Weinberger MH, Fineberg NS, Fineberg SE, et al. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001; 37: 429-32.
5. Cowley AW Jr, Mattson DL, Lu Set al. The renal medulla and hypertension. Hypertension. 1995; 25: 663-73.
6. Li N, Yi F, dos Santos EA, et al. Role of renal medullary heme oxygenase in the regulation of pressure natriuresis and arterial blood pressure. Hypertension. 2007; 49: 148-54.
7. Mattson DL. Importance of the renal medullary circulation in the control of sodium excretion and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2003; 284: R13-27.
8. Szentivanyi M Jr, Zou A-P, Mattson DL, et al. Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol. 2002; 283: R266-72.
9. Tan DY, Meng S, Cason GW, et al. Mechanisms of salt-sensitive hypertension: role of inducible nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol. 2000; 279: R2297-303.
10. Bergstrom G, Evans RG. Mechanisms underlying the antihypertensive functions of the renal medulla. Acta Physiol Scand. 2004; 181: 475-86.
11. Li N, Chen L, Yi F, et al. Salt-sensitive hypertension induced by decoy of transcription factor hypoxia-inducible factor-1{alpha} in the renal medulla. Circ Res. 2008; 102: 1101-8.
12. Zou A-P, Billington H, Su N, et al. Expression and actions of heme oxygenase in the renal medulla of rats. Hypertension. 2000; 35: 342-7.
13. Mattson DL, Higgins DJ. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension. 1996; 27: 688-92.
14. Zewde T, Mattson DL. Inhibition of cyclooxygenase-2 in the rat renal medulla leads to sodium-sensitive hypertension. Hypertension. 2004; 44: 424-8.
15. Yang T, Singh I, Pham H, et al. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol Renal Physiol. 1998; 274: F481-9.
16. Harris RC, Breyer MD. Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol. 2001; 281: F1-11.
17. Yao B, Harris RC, Zhang M-Z. Interactions between 11{beta}-hydroxysteroid dehydrogenase and COX-2 in kidney. Am J Physiol Regul Integr Comp Physiol. 2005; 288: R1767-73.
18. Mattson DL, Maeda CY, Bachman TD, et al. Inducible nitric oxide synthase and blood pressure. Hypertension. 1998; 31: 15-20.
19. Nakanishi K, Hara N, Nagai Y. Salt-sensitive hypertension in conscious rats induced by chronic nitric oxide blockade. Am J Hypertens. 2002; 15: 150-6.
20. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001; 294: 1337-40.
21. Ivan M, Kondo K, Yang H, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001; 292: 464-8.
22. Jaakkola P, Mole DR, Tian Y-M, et al. Targeting of HIF-alpha to the von Hippel-Lindau Ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001; 292: 468-72.
23. Callapina M, Zhou J, Schnitzer S, et al. Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1alpha accumulation - implications for prolyl hydroxylase activity and iron. Exp Cell Res. 2005; 306: 274-84.
24. Page EL, Chan DA, Giaccia AJ, et al. Hypoxia-inducible factor-1{alpha} stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol Biol Cell. 2008; 19: 86-94.
25. McMahon S, Charbonneau M, Grandmont S, et al. Transforming growth factor beta1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J Biol Chem. 2006; 281: 24171-81.
26. Baek JH, Mahon PC, Oh J, et al. OS-9 interacts with hypoxia-inducible factor 1alpha and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1alpha. Mol Cell. 2005; 17: 503-12.
27. Tug S, Delos Reyes B, Fandrey J, et al. Non-hypoxic activation of the negative regulatory feedback loop of prolyl-hydroxylase oxygen sensors. Biochem Biophys Res Commun. 2009; 384: 519-23.
28. Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001; 107: 43-54.
29. Li N, Yi F, Sundy CM, et al. Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys. Am J Physiol Renal Physiol. 2007; 292: F207-16.
30. Takeda K, Cowan A, Fong G-H. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation. 2007; 116: 774-81.
31. Rosenberger C, Rosen S, Shina A, et al. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney. Nephrol Dial Transplant. 2008; 23: 3472-8.
32. Takeda K, Aguila HL, Parikh NS, et al. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood. 2008; 111: 3229-35.
33. Schodel J, Klanke B, Weidemann A, et al. HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury. Am J Pathol. 2009; 174: 1663-74.
34. Wang Z, Zhu Q, Xia M, et al. Hypoxia-inducible factor prolyl-hydroxylase 2 senses high-salt intake to increase hypoxia inducible factor 1alpha levels in the renal medulla. Hypertension. 2010; 55: 1129-36.
35. Liu Y, Singh RJ, Usa K, et al. Renal medullary 11{beta}-hydroxysteroid dehydrogenase type 1 in Dahl salt-sensitive hypertension. Physiol Genomics. 2008; 36: 52-8.
36. Hosseinkhani H, Aoyama T, Ogawa O, et al. Ultrasound enhances the transfection of plasmid DNA by non-viral vectors. Curr Pharm Biotechnol. 2003; 4: 109-22.
37. Newman CMH, Bettinger T. Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther. 2007; 14: 465-75.
38. Chumakova OV, Liopo AV, Andreev VG, et al. Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett. 2008; 261: 215-25.
39. Huang J, Zhao Q, Mooney SM, et al. Sequence determinants in hypoxia-inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J Biol Chem. 2002; 277: 39792-800.
40. Percy MJ, Zhao Q, Flores A, et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci USA. 2006; 103: 654-9.
41. Lan HY, Mu W, Tomita N, et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 Using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol. 2003; 14: 1535-48.
42. Yi F, Xia M, Li N, et al. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension. 2009; 53: 90-6.
43. Richard-Fiardo P, Payen E, Chevre R, et al. Therapy of anemia in kidney failure, using plasmid encoding erythropoietin. Hum Gene Ther. 2008; 19: 331-42.
44. Ng Y-Y, Hou C-C, Wang W, et al. Blockade of NF[kappa]B activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int. 2005; 67: S83-91.
45. Yang J, Dai C, Liu Y. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice. Gene Ther. 2001; 8: 1470-9.
46. Dos Santos EA, Dahly-Vernon AJ, Hoagland KM, et al. Inhibition of the formation of EETs and 20-HETE with 1-aminobenzotriazole attenuates pressure natriuresis. Am J Physiol Regul Integr Comp Physiol. 2004; 287: R58-68.
47. DiBona GF, Sawin LL. Effect of metoprolol administration on renal sodium handling in experimental congestive heart failure. Circulation. 1999; 100: 82-6.
48. Dibona GF, Jones SY, Sawin LL. Angiotensin receptor antagonist improves cardiac reflex control of renal sodium handling in heart failure. Am J Physiol Heart Circ Physiol. 1998; 274: H636-41.
49. Li P, Morris M, Ferrario CM, et al. Cardiovascular, endocrine, and body fluid-electrolyte responses to salt loading in mRen-2 transgenic rats. Am J Physiol Heart Circ Physiol. 1998; 275: H1130-7.
50. Zhu Q, Wang Z, Xia M, et al. Silencing of hypoxia-inducible factor-1{alpha} Gene Attenuated Angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension. 2011; 58: 657-64.
51. Granger JP, Alexander BT, Llinas M. Mechanisms of pressure natriuresis. Curr Hypertens Rep. 2002; 4: 152-9.
52. Evans RG, Majid DS, Eppel GA. Mechanisms mediating pressure natriuresis: what we know and what we need to find out. Clin Exp Pharmacol Physiol. 2005; 32: 400-9.
53. Gross JM, Dwyer JE, Knox FG. Natriuretic response to increased pressure is preserved with COX-2 inhibitors. Hypertension. 1999; 34: 1163-7.
54. Rodriguez F, Kemp R, Balazy M, et al. Effects of exogenous heme on renal function: role of heme oxygenase and cyclooxygenase. Hypertension. 2003; 42: 680-4.
55. Majid DS, Navar LG. Nitric oxide in the control of renal hemodynamics and excretory function. Am J Hypertens. 2001; 14: 74S-82S.
56. Majid DS, Navar LG. Nitric oxide in the mediation of pressure natriuresis. Clin Exp Pharmacol Physiol. 1997; 24: 595-9.
57. Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003; 41: 625-33.